| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/ENDO.137.1.8536621 |
| P8608 | Fatcat ID | release_kipr5m6lp5bdtmnh6iwbapikey |
| P698 | PubMed publication ID | 8536621 |
| P2093 | author name string | Smith CE | |
| Krause WJ | |||
| Fan X | |||
| Currie MG | |||
| Freeman RH | |||
| Forte LR | |||
| Chin DT | |||
| Hamra FK | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 257-265 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | Prouroguanylin and proguanylin: purification from colon, structure, and modulation of bioactivity by proteases | |
| P478 | volume | 137 |
| Q39961335 | A novel role for uroguanylin in the regulation of sodium balance |
| Q35572696 | A uroguanylin-GUCY2C endocrine axis regulates feeding in mice |
| Q34214745 | Agonist-specific compartmentation of cGMP action in myometrium |
| Q54966690 | BTCI enhances guanylin-induced natriuresis and promotes renal glomerular and tubular effects |
| Q91988489 | Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation |
| Q36908897 | Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules |
| Q38223422 | Current understanding of guanylin peptides actions. |
| Q36918732 | Dietary salt regulates uroguanylin expression and signaling activity in the kidney, but not in the intestine |
| Q24672268 | E. coli heat-stable enterotoxin and guanylyl cyclase C: new functions and unsuspected actions |
| Q52644144 | Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. |
| Q33831378 | Guanylin peptides: renal actions mediated by cyclic GMP. |
| Q54561570 | Guanylyl Cyclase Receptors and Guanylin-like Peptides in Reptilian Intestine |
| Q40901382 | Increased urinary excretion of uroguanylin in patients with congestive heart failure |
| Q35064425 | Low salt intake down-regulates the guanylin signaling pathway in rat distal colon |
| Q36160919 | Mechanisms of actions of guanylin peptides in the kidney |
| Q38288274 | Natriuretic hormones in brain function |
| Q78841847 | Occurrence and localization of uroguanylin in the aging human prostate |
| Q38178827 | Pendrin, a novel transcriptional target of the uroguanylin system |
| Q40710524 | Proguanylin secretion and the role of negative-feedback inhibition in a villous epithelial cell line |
| Q28582303 | Purification, cDNA sequence, and tissue distribution of rat uroguanylin |
| Q39922850 | Receptor guanylyl cyclase C (GC-C): regulation and signal transduction |
| Q34423605 | Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity |
| Q42064429 | Role of the prosequence of guanylin |
| Q37312567 | The natriuretic peptide uroguanylin elicits physiologic actions through 2 distinct topoisomers |
| Q35760474 | The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor) |
| Q73783911 | Urine and plasma levels of uroguanylin and its molecular forms in renal diseases |
| Q28572347 | Uroguanylin gene expression in the alimentary tract and extra-gastrointestinal tissues |
| Q39998559 | Uroguanylin inhibits proliferation of pancreatic cancer cells |
| Q36908915 | Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide |
Search more.